Astera Labs (NASDAQ:ALAB) Now Covered by BMO Capital Markets

Investment analysts at BMO Capital Markets began coverage on shares of Astera Labs (NASDAQ:ALAB) in a note issued to investors on Thursday, Briefing.com reports. The brokerage set an “outperform” rating and a $375.00 price target on the stock. BMO Capital Markets‘s price target would indicate a potential upside of 67.96% from the company’s previous close.

Several other analysts also recently commented on the stock. Needham & Company LLC decreased their target price on shares of Astera Labs from $425.00 to $300.00 and set a “buy” rating for the company in a research report on Wednesday. Susquehanna cut their price target on shares of Astera Labs from $310.00 to $258.00 and set a “neutral” rating on the stock in a report on Wednesday. Northland Securities upgraded shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a report on Wednesday. Morgan Stanley lifted their price objective on shares of Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a research note on Wednesday. Finally, UBS Group decreased their price objective on shares of Astera Labs from $300.00 to $290.00 and set a “neutral” rating for the company in a report on Wednesday. Thirteen investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $320.85.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $223.27 on Thursday. The firm has a market cap of $38.73 billion, a price-to-earnings ratio of 88.95 and a beta of 3.85. Astera Labs has a 52-week low of $97.89 and a 52-week high of $499.48. The stock has a 50-day simple moving average of $304.94 and a 200-day simple moving average of $255.78.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.19 by $0.13. Astera Labs had a return on equity of 27.30% and a net margin of 29.64%. The business had revenue of $584.90 million during the quarter, compared to analysts’ expectations of $550.78 million. During the same quarter in the previous year, the business posted $0.49 EPS. The firm’s quarterly revenue was up 153.6% compared to the same quarter last year. As a group, equities research analysts predict that Astera Labs will post 2.71 earnings per share for the current year.

Insider Transactions at Astera Labs

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Sanjay Gajendra sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief operating officer owned 1,119,038 shares in the company, valued at approximately $380,864,583.30. This trade represents a 7.49% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 396,059 shares of company stock worth $123,408,470. 10.40% of the stock is currently owned by company insiders.

Institutional Trading of Astera Labs

Institutional investors and hedge funds have recently modified their holdings of the company. Lido Advisors LLC raised its holdings in Astera Labs by 114.8% in the 3rd quarter. Lido Advisors LLC now owns 27,630 shares of the company’s stock worth $9,836,000 after acquiring an additional 14,768 shares during the period. Keybank National Association OH lifted its position in Astera Labs by 139.8% during the 3rd quarter. Keybank National Association OH now owns 2,103 shares of the company’s stock worth $749,000 after acquiring an additional 1,226 shares during the last quarter. Csenge Advisory Group acquired a new position in Astera Labs during the 3rd quarter worth $534,000. 71 West Capital Partners bought a new stake in Astera Labs during the third quarter valued at about $208,000. Finally, AlphaCore Capital LLC bought a new stake in Astera Labs during the third quarter valued at about $752,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

More Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Strong quarter and outlook: Q3 revenue reached a record $584.9 million, up 153.6% year over year, while EPS of $1.32 beat estimates. Scorpio X-Series switches drove growth, and the company forecast Q4 revenue of $730 million to $750 million, citing AI connectivity demand. Astera Labs Q3 Earnings Beat Estimate on Scorpio X-Series Strength
• Positive Sentiment: Some analysts remain bullish: Northland upgraded ALAB to Outperform with a $315 target, and Morgan Stanley raised its target to $389 while retaining an Overweight rating. Astera Labs Upgraded to Outperform at Northland Securities
• Neutral Sentiment: Director Michael Hurlston resigned from Astera Labs’ board; the announcement did not provide a reason. Astera Labs Director Resigns from Board
• Negative Sentiment: Valuation and estimate concerns are weighing on the stock: Shares fell despite the earnings beat, as investors focused on ALAB’s rich valuation and analysts’ forecast reductions. TD Cowen cut its target to $225 and rated the stock Hold; Susquehanna lowered its target to $258 and moved to Neutral. Rising costs, competition—including Marvell’s optical push—and reliance on a limited number of customers add to the risks. Astera Labs Stock Drops After Q3 Results Spotlight Rich Valuation

About Astera Labs

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.